Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study Finds Majority of Women Willing to Accept Cervical Cancer Vaccine for Self and Children

23.03.2005


In a study of 200 women, a group of physicians has found that a vast majority of women would be willing to take a cervical cancer vaccine themselves and would allow it to be administered to their children. The findings, which were presented at the Society of Gynecologic Oncologist’s (SGO) Annual Meeting on Women’s Cancer in Miami, describes women’s attitudes toward a potential cervical cancer vaccine, focusing on their willingness to accept it for themselves, and their daughters and sons. It is the first study to examine women’s perceptions of a vaccine for both girls and boys.

Specifically, the study included 200 surveys conducted between February and December 2004 at gynecology and adolescent medical clinics at The University of Texas, Galveston. Women with children between the ages of eight and 14 were asked to take the survey, which was available in both English and Spanish. Women also received an education statement that explained that the human papillomavirus (HPV) is a virus that can cause cervical cancer. The statement also explained that scientific studies showed that a cervical cancer vaccine may be available within the next couple of years, and that this vaccine would work by preventing HPV, which is transmitted through sexual contact.

Results showed that 76 percent of women surveyed would be willing to accept a cervical cancer vaccine for themselves. Sixty-seven percent of women who had a daughter would consent to have their child vaccinated, compared to 64 percent of women with a son. Stated reasons for women not accepting the vaccine included unknown side effects and not currently being sexually active. Reasons for refusing consent for their children to be vaccinated included: unknown side effects, the belief that minors are not sexually active, and for boys, the belief that there was no direct benefit to them.



As the vaccine would need to be administrated prior to first sexual activity, 23 percent of women who were not willing to vaccinate their children stated that they did not want their child to participate in sex education. In the survey, it was found that 11 years of age was the mean age noted by participants as an appropriate time to provide children with sex education. "This study shows that education will be key to acceptance of the vaccine,” said Diane C. Bodurka, MD, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center. “Given that the vaccine may be available in the next five to 10 years, it is critical that we begin educating parents, especially mothers, now about how the vaccine will be crucial to the prevention of cervical cancer. It is also important for everyone to understand that a vaccine will be aimed at both boys and girls, and how this will help prevent the disease worldwide.”

Factors influencing a woman’s acceptance of the vaccine included their acceptance of all previously recommended vaccines for a child and acceptance of the vaccine for themselves. Neither demographic considerations, such as income, religion, race and education, nor a history of an abnormal Pap test were found to alter the patterns of potential acceptance of the vaccine.

Sarah Handza | EurekAlert!
Further information:
http://www.sgo.org

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Strathclyde-led research develops world's highest gain high-power laser amplifier

The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.

The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

New insights into the ancestors of all complex life

29.05.2017 | Earth Sciences

New photocatalyst speeds up the conversion of carbon dioxide into chemical resources

29.05.2017 | Life Sciences

NASA's SDO sees partial eclipse in space

29.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>